DK1119345T3 - Indkapsling af fölsomme flydende bestanddele i en matrix til opnåelse af adskilte opbevaringsstabile partikler - Google Patents

Indkapsling af fölsomme flydende bestanddele i en matrix til opnåelse af adskilte opbevaringsstabile partikler

Info

Publication number
DK1119345T3
DK1119345T3 DK99951433T DK99951433T DK1119345T3 DK 1119345 T3 DK1119345 T3 DK 1119345T3 DK 99951433 T DK99951433 T DK 99951433T DK 99951433 T DK99951433 T DK 99951433T DK 1119345 T3 DK1119345 T3 DK 1119345T3
Authority
DK
Denmark
Prior art keywords
encapsulation
matrix
storage stable
liquid constituents
stable particles
Prior art date
Application number
DK99951433T
Other languages
English (en)
Inventor
Lengerich Bernhard H Van
Original Assignee
Gen Mills Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/233,443 external-priority patent/US7201923B1/en
Application filed by Gen Mills Inc filed Critical Gen Mills Inc
Application granted granted Critical
Publication of DK1119345T3 publication Critical patent/DK1119345T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/20—Partially or completely coated products
    • A21D13/28—Partially or completely coated products characterised by the coating composition
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/117—Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
    • A23L7/135—Individual or non-extruded flakes, granules or shapes having similar size, e.g. breakfast cereals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L9/00—Puddings; Cream substitutes; Preparation or treatment thereof
    • A23L9/10—Puddings; Dry powder puddings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
    • B29B7/00—Mixing; Kneading
    • B29B7/002—Methods
    • B29B7/007—Methods for continuous mixing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
    • B29B7/00—Mixing; Kneading
    • B29B7/30—Mixing; Kneading continuous, with mechanical mixing or kneading devices
    • B29B7/34—Mixing; Kneading continuous, with mechanical mixing or kneading devices with movable mixing or kneading devices
    • B29B7/38—Mixing; Kneading continuous, with mechanical mixing or kneading devices with movable mixing or kneading devices rotary
    • B29B7/46—Mixing; Kneading continuous, with mechanical mixing or kneading devices with movable mixing or kneading devices rotary with more than one shaft
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
    • B29B9/00—Making granules
    • B29B9/12—Making granules characterised by structure or composition
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/25—Component parts, details or accessories; Auxiliary operations
    • B29C48/36—Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die
    • B29C48/395—Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die using screws surrounded by a cooperating barrel, e.g. single screw extruders
    • B29C48/40—Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die using screws surrounded by a cooperating barrel, e.g. single screw extruders using two or more parallel screws or at least two parallel non-intermeshing screws, e.g. twin screw extruders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2220/00—Biochemical treatment
    • A23C2220/20—Treatment with microorganisms
    • A23C2220/204—Use of bacteria which are encapsulated, entrapped or immobilised; Fermentation with these bacteria
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29B—PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS
    • B29B9/00—Making granules
    • B29B9/02—Making granules by dividing preformed material
    • B29B9/06—Making granules by dividing preformed material in the form of filamentary material, e.g. combined with extrusion
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DK99951433T 1998-10-09 1999-10-06 Indkapsling af fölsomme flydende bestanddele i en matrix til opnåelse af adskilte opbevaringsstabile partikler DK1119345T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10370098P 1998-10-09 1998-10-09
US10969698P 1998-11-24 1998-11-24
US09/233,443 US7201923B1 (en) 1998-03-23 1999-01-20 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
PCT/US1999/020905 WO2000021504A1 (en) 1998-10-09 1999-10-06 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles

Publications (1)

Publication Number Publication Date
DK1119345T3 true DK1119345T3 (da) 2009-08-03

Family

ID=27379589

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99951433T DK1119345T3 (da) 1998-10-09 1999-10-06 Indkapsling af fölsomme flydende bestanddele i en matrix til opnåelse af adskilte opbevaringsstabile partikler

Country Status (13)

Country Link
EP (1) EP1119345B1 (da)
JP (1) JP5408684B2 (da)
AR (1) AR020729A1 (da)
AT (1) ATE429813T1 (da)
AU (1) AU777977B2 (da)
CA (1) CA2345815C (da)
CO (1) CO5150196A1 (da)
DE (1) DE69940821D1 (da)
DK (1) DK1119345T3 (da)
ES (1) ES2326502T3 (da)
PE (1) PE20001321A1 (da)
PT (1) PT1119345E (da)
WO (1) WO2000021504A1 (da)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
AU2001291646A1 (en) * 2000-10-02 2002-04-15 Novozymes A/S Particles containing active in visco-elastic liquids
US6617026B2 (en) 2000-10-02 2003-09-09 Novozymes A/S Particles containing active in visco-elastic liquids
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US7431986B2 (en) * 2002-07-24 2008-10-07 General Mills, Inc. Encapsulation of sensitive components using pre-emulsification
DE102004039196B4 (de) 2004-08-12 2008-07-31 Dr.Kamprad Kg Neue Formulierung für L-Tryptophan
US7318920B2 (en) * 2004-09-27 2008-01-15 Ez-Med Company Low water activity nutritional product having beneficial microbial and high oil content
KR20070111490A (ko) * 2005-01-18 2007-11-21 이뮤솔 인코퍼레이티드 신규한 퀴놀리늄 염 및 유도체
MX2007016021A (es) 2005-06-17 2008-04-16 Australian Nuclear Science Tec Particulas que tienen material hidrofobico en estas.
CN101242814A (zh) 2005-06-17 2008-08-13 澳大利亚核科学技术组织 包含可释放掺杂剂的粒子
AU2006257726B2 (en) * 2005-06-17 2010-09-09 Australian Nuclear Science And Technology Organisation Particles having hydrophobic material therein
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
CA2633238A1 (en) 2005-12-16 2007-07-05 Oxthera, Inc. Compositions and methods for oxalate reduction
DK3095447T3 (da) 2006-02-03 2022-01-31 Opko Renal Llc Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3
PL2679228T3 (pl) 2006-06-21 2018-07-31 Opko Ireland Global Holdings, Ltd. Terapia z użyciem środka do uzupełniania witaminy D i środka do zastępowania hormonami witaminy D
US8703191B2 (en) 2006-07-25 2014-04-22 Intelgenx Corp. Controlled-release pharmaceutical tablets
WO2008134518A2 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Methods and compounds for vitamin d therapy
EP3225243A1 (en) 2007-04-25 2017-10-04 Opko Renal, LLC Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
CN104257667B (zh) 2007-04-25 2019-06-04 欧普科Ip 控股Ii 有限公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的方法和组合物
PL2481400T3 (pl) 2007-04-25 2015-04-30 Opko Ip Holdings Ii Inc Sposoby i kompozycje dawki doustnej do kontrolowanego uwalniania związku będącego witaminą D
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
ES2954932T3 (es) 2008-04-02 2023-11-27 Eirgen Pharma Ltd Métodos, composiciones, usos y kits útiles para la deficiencia de vitamina D y trastornos relacionados
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
EP2318035B1 (en) 2008-07-01 2019-06-12 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
US9107419B2 (en) 2009-01-06 2015-08-18 Curelon Llc Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces
EP2947100B1 (en) 2009-01-06 2019-05-08 Galenagen, LLC Oral compositions for the treatment or the prevention of infections by E. Coli
DE202009001095U1 (de) 2009-01-26 2010-03-11 Igv Institut Für Getreideverarbeitung Gmbh Verkapselte Wirkstoffe in bioaktiver Matrix
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US20100310728A1 (en) * 2009-06-05 2010-12-09 General Mills, Inc. Encapsulated omega-3 fatty acids for baked goods production
JP5810082B2 (ja) * 2009-07-03 2015-11-11 カーギル インコーポレイテッド 粒状フレーバー送達系、その製造方法及びその使用
US20110086085A1 (en) * 2009-10-13 2011-04-14 Wenzel Scott W Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
US8926308B2 (en) 2010-04-21 2015-01-06 Intercontinental Great Brands Llc Dough extruders and methods
WO2012017012A1 (de) 2010-08-05 2012-02-09 Basf Se Stabilisator
MX362974B (es) 2011-04-21 2019-02-28 Curemark Llc Compuestos para el tratamiento de alteraciones neuropsiquiatricas.
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
US9560877B2 (en) 2012-03-13 2017-02-07 General Mills, Inc. Cereal-based product with improved eating quality fortified with dietary fiber and/or calcium
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
EP3003246B1 (en) 2013-05-31 2020-11-18 Victor Bronshtein Polymeric compositions containing ambient-temperature stable biopharmaceuticals & methods for formulation thereof
JP6539274B2 (ja) 2013-08-12 2019-07-03 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 押出成形された即放性乱用抑止性丸剤
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
JP6371463B2 (ja) 2014-07-17 2018-08-08 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 即時放出性乱用抑止性液体充填剤形
EP3193925A2 (en) 2014-08-07 2017-07-26 OPKO Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin d
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
WO2017108131A1 (en) * 2015-12-23 2017-06-29 Sonneveld Group B.V. Dough mixture comprising particles comprised of starch for the production of bakery products with an open crumb structure
JP5945087B1 (ja) * 2016-03-16 2016-07-05 株式会社大貴 排泄物処理材の製造方法及び製造装置
MX2018011820A (es) 2016-03-28 2019-01-24 Opko Ireland Global Holdings Ltd Metodos de tratamiento con vitamina d.
EP3442352A4 (en) * 2016-04-14 2020-03-11 Mars, Incorporated COMPOUNDS THAT MODULATE CALCIUM SENSITIVE RECEPTOR ACTIVITY TO MODULATE KOKUMI TASTE AND PET FOOD PRODUCTS CONTAINING THE SAME
WO2019175331A1 (en) * 2018-03-15 2019-09-19 Dsm Ip Assets B.V. Extrusion of oxidable actives
BR112020018494A2 (pt) * 2018-03-15 2020-12-29 Dsm Ip Assets B.V. Extrudado que compreende vitamina a
CN109432817A (zh) * 2018-11-02 2019-03-08 江阴天江药业有限公司 一种含热敏性有效成分的中药的自动化提取分离方法及配方颗粒制备方法
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
CN113350315B (zh) * 2021-06-10 2022-09-06 黑龙江澳利达奈德制药有限公司 一种别嘌醇缓释胶囊及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191015312A (en) 1910-06-25 1911-03-23 John Hutcheon Improved Process of Producing Cooked Foods Impregnated with certain Bacteria.
US3786123A (en) * 1971-01-25 1974-01-15 S Katzen Method for stabilizing and preserving nutrients and products
EP0202409A3 (en) 1985-03-25 1989-02-01 Miles Inc. A process for the production of viable and stable dry microorganisms for food and agricultural purposes
US5314692A (en) * 1987-08-24 1994-05-24 Cultor Ltd. Enzyme premix for feed and method
WO1990015537A1 (en) 1989-06-07 1990-12-27 Nabisco Brands, Inc. Extrusion baking of cookies having liposome encapsulated ingredients
US5079012A (en) * 1989-06-07 1992-01-07 Nabisco Brands, Inc. Shelf stable cookie product containing heat and shear sensitive additives and method of making
US5074902A (en) 1990-07-30 1991-12-24 Connick Jr William J Granular products containing fungi encapsulated in a wheat gluten matrix for biological control of weeds
DE4041752A1 (de) 1990-12-24 1992-06-25 Henkel Kgaa Enzymzubereitung fuer wasch- und reinigungsmittel
US5508053A (en) 1993-08-13 1996-04-16 Kraft Foods, Inc. Method for producing vegetable pasta
ATE277739T1 (de) * 1996-10-28 2004-10-15 Gen Mills Inc Einbettung und einkapselung von teilchen zur kontrollierten abgabe
ES2272005T3 (es) * 1997-06-04 2007-04-16 Basf Aktiengesellschaft Granulados de fosfatasa a base de almidon.
WO1999048372A1 (en) 1998-03-23 1999-09-30 General Mills, Inc. Encapsulation of components into edible products

Also Published As

Publication number Publication date
EP1119345A1 (en) 2001-08-01
WO2000021504A8 (en) 2000-06-22
JP2002527375A (ja) 2002-08-27
ATE429813T1 (de) 2009-05-15
ES2326502T3 (es) 2009-10-13
AU6387299A (en) 2000-05-01
JP5408684B2 (ja) 2014-02-05
AU777977B2 (en) 2004-11-04
DE69940821D1 (de) 2009-06-10
EP1119345B1 (en) 2009-04-29
CA2345815C (en) 2011-02-08
CA2345815A1 (en) 2000-04-20
EP1119345A4 (en) 2004-06-16
AR020729A1 (es) 2002-05-29
CO5150196A1 (es) 2002-04-29
PT1119345E (pt) 2009-07-27
PE20001321A1 (es) 2000-12-01
WO2000021504A1 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
DK1119345T3 (da) Indkapsling af fölsomme flydende bestanddele i en matrix til opnåelse af adskilte opbevaringsstabile partikler
DE60041822D1 (de) Verkapselung empfindlicher flüssiger komponenten in eine matrix zur gewinnung diskreter lagerbeständiger partikel
ID25476A (id) Komposisi-komposisi yang tidak dapat larut untuk mengontrol glukosa darah
DK1065936T3 (da) Indkapsling af bestanddele i spiselige produkter
DE69635904D1 (de) Sauerstoffentfernende zusammensetzungen mit geringer wanderung
DE69940904D1 (de) Pharmazeutische zusammensetzung enthaltend epothilone
ID23700A (id) Komposisi kosmetik dan/atau bahan dermatologi yang mengandung suatu turunan silamnol termetilasi dan suatu turunan protein tanaman terhidrolisasi
DE68922650T2 (de) Knotenpunkt zur schnellen Paketvermittlung in der optoelektrischen Technologie.
DE60045569D1 (de) Zwei interpenetrierende Festelektrolyten enthaltende Verbundelektrode
DK0981336T3 (da) Anvendelse af peroxygenforbindelser til bekæmpelse af digital dermatitis
DE60017392D1 (de) Avenanthramides aus haferextrakt enthaltende zusammensetzungen
DK1698699T3 (da) Forbedret ekspression af insekticidt CRY3B-protein i planter
ID29468A (id) Komposisi farmasi yang stabil dalam bentuk liofil
GB2375351B (en) Retrodifferentiation of cells to form undifferentiated cells
ID29286A (id) Pemasukan zat-zat aktif pada matriks pembawa
DE69710442T2 (de) Flüssigkristallphase enthaltende Lipidzusammensetzung
AU6556198A (en) Absorbent structures comprising fluid storage members with improved ability to dewater high flux distribution members
ATE242968T1 (de) In (s) enantiomer angereicherte fipronil zusammensetzung
IT8848193A0 (it) Composizione detersiva non acquosa stabile contenente una carica di bassa densita'
DE69911463D1 (de) Strukturierte flüssige waschmittelzusammensetzung
DE69823187D1 (de) Eine n-undecylenoyl-aminosaure enthaltende zusammensetzung; anwendung in der kosmetik
IT8747701A0 (it) Composizioni stabili allo stoccaggio di assorbenti uv
FR2645922B1 (fr) Organe d'assemblage destine a etre insere dans un materiau fragile notamment
BR9916230A (pt) Composição detergente lìquida embalada
GB2335434B (en) Encapsulated liquid detergent incorporation in tableted detergent composition